Ajaz Bulbul, MD

Articles by Ajaz Bulbul, MD

Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer

ByAjaz Bulbul, MD,Patrick M. Forde, MD,Ayesha Murtuza, MD,Brian Woodward,Hannah Yang,Ingmar Bastian,Parissa K. Ferguson, MS,Fernando Lopez-Diaz, PhD,David S. Ettinger, MD,Hatim Husain, MD

April 15th 2018

In this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.

Latest Updated Articles

Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer
Published: April 15th 2018 | Updated:

Ajaz Bulbul, MD

Articles by Ajaz Bulbul, MD

Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer

Latest Updated Articles

Trending on CancerNetwork

ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice

FDA Approves Revumenib in R/R NPM1-Mutant AML

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment

Addressing Systemic Barriers to Dermatologic Consultation in Oncology Care